Boston Scientific (BSX) Misses Q4 EPS by 2c; Guides

Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.45, $0.02 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $3.24 billion versus the consensus estimate of $3.24 billion.

GUIDANCE:

Boston Scientific sees Q1 2023 EPS of $0.42-$0.44, versus the consensus of $0.44.

Boston Scientific sees FY2023 EPS of $1.86-$1.93, versus the consensus of $1.93.

For earnings history and earnings-related data on Boston Scientific (BSX) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics